Bid Radar · U.S. federal contract opportunity
SAFE-PLASMA Protocol
- Agency
- DEPT OF DEFENSE · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY
- Solicitation number
- HT9427-27-SSN-701
- Notice type
- Sources Sought
- Posted
- Nov 10, 2026
- Respond by
- Nov 16, 2026, 2:00 PM (Eastern Time)
- Place of performance
- MD
- NAICS
- 541715
Description
The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval.
Source: SAM.gov (U.S. General Services Administration), read on Nov 14, 2026. Bid Radar is a private service and is not affiliated with or endorsed by the U.S. government. Ver em português